Showing results (701-710 of 829) with videos related to
Sort By:
Pageof 83
Journal of Clinical Lipidology|May 13, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.Journal of the American Heart Association|February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID StudyMalcolm West, Adrienne Kirby, Ralph A Stewart, et al.Atherosclerosis|October 2, 2018
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemiaMartin S Hagger, Sarah J Hardcastle, Miao Hu, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 7, 2021
The effect of Vitamin-K1 and Colchicine on Vascular Calcification Activity in subjects with Diabetes Mellitus (ViKCoVaC): A double-blind 2x2 factorial randomized controlled trialJamie W Bellinge, Roslyn J Francis, Sing Ching Lee, et al.Atherosclerosis|April 16, 2026
Liver transplantation in severe homozygous familial hypercholesterolaemia: a scoping reviewJing Pang, Samuel S Gidding, Erin Kelty, et al.The New England Journal of Medicine|May 29, 2024
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed HyperlipidemiaRobert S Rosenson, Daniel Gaudet, Robert A Hegele, et al.European Heart Journal Open|July 2, 2026
Overview of methodology and characteristics of national acute coronary syndrome registries in high-income countries: a scoping reviewJustine Chan, Natalie Ward, Judith Finn, et al.Journal of the American College of Cardiology|April 4, 2014
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumabErik Stroes, David Colquhoun, David Sullivan, et al.Journal of the American Heart Association|October 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart DiseaseRalph A H Stewart, Kristy P Robledo, Andrew M Tonkin, et al.Atherosclerosis|January 26, 2021
LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trialAntonio J Vallejo-Vaz, Chris J Packard, Brian A Ference, et al.Pageof 83